The Latest Breaking News from Prostate Cancer

A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The study, the largest of its kind, recruited 7,500 men from eastern, southern and west Africa. The study is especially important because African men have a high risk of prostate cancer.

BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung and prostate cancer patients.

Janux Therapeutics reports updated clinical data for JANX007, highlighting significant efficacy, safety, and durability in advanced prostate cancer patients.

Shares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment.

Every so often there is an urgent call for a national prostate cancer screening programme to be introduced, usually following the diagnosis of a high-profile person with the disease.

Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca's Truqap (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) demonstrated a statistically

Nearly one in two men in Scotland will be affected by prostate disease at some point in their lives, according to Prostate Scotland.

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

A ‘Man Van’ mobile testing unit was sent to target at-risk groups in London, working with local hospitals and community leaders to drive awareness.

Hollywood director Steve McQueen has revealed he secretly battled prostate cancer two years ago and underwent surgery but is now "fully recovered and fully functional".

The Health Secretary also pointed to inequalities in prostate cancer diagnoses, with black men two and a half times more likely to die than white men.